Newest figures come from the 10-Q for Q1 FY2027, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BENFW SEC filings page.
Beneficient Warrant (BENFW) reported $40K in revenue for fiscal year 2026, down 9.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Balance-sheet contraction is occurring alongside persistent operating cash needs, leaving financing structure more important than revenue economics.
Net income swung from$51.2M positive in FY2025 to-$87.4M in FY2026, while operating cash flow stayed near-$39M in both years. That disconnect means reported earnings are not tracking the cash demands of the business, so profitability alone does not describe its operating condition.
Total assets fell from
FY2026 capital expenditures were just
Financial Health Signals
Beneficient Warrant does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Beneficient Warrant passes 2 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 1 of 4 profitability signals pass, both operating efficiency signals pass.
Beneficient Warrant reported a net loss of $87.4M while operations used $38.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Beneficient Warrant reported an operating loss of $166.5M against $18.8M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Beneficient Warrant generated $12.2M in revenue in Q1 2027. This represents an increase of 121550.0% from the same quarter a year earlier.
Beneficient Warrant's EBITDA was -$252K in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 99.7% from the same quarter a year earlier.
Beneficient Warrant reported -$6.8M in net income in Q1 2027. This represents an increase of 89.6% from the same quarter a year earlier.
Not reported for Q1 2027.
Cash & Balance Sheet
Beneficient Warrant recorded an outflow of $4.1M in free cash flow in Q1 2027, representing a cash shortfall after capex. This represents an increase of 62.4% from the same quarter a year earlier. Against the prior quarter it is down 3.1%.
Beneficient Warrant held $5.6M in cash as of Q1 2027; long-term debt is not reported for that period.
Not reported for Q1 2027.
Margins & Returns
Beneficient Warrant's operating margin was -3.1% in Q1 2027, reflecting core business profitability. No change is given against Q1 2026: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Beneficient Warrant's net profit margin was -55.8% in Q1 2027, showing the share of revenue converted to profit. No change is given against Q1 2026: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not reported for Q1 2027.
Not reported for Q1 2027.
Capital Allocation
Beneficient Warrant reported no capital expenditure in Q1 2027. This represents a decrease of 100.0% from the same quarter a year earlier.
Not reported for Q1 2027.
Not reported for Q1 2027.
BENFW Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.2M+121550.0% | N/A | $18.7M+422393.8% | $10K+16.8% | $10K-0.5% | N/A | $4K | $9K |
| SG&A Expenses | $2.8M-15.1% | N/A | $3.0M+102665.4% | $2.4M+33943.4% | $3.3M+86419.5% | N/A | $3K-100.0% | $7K-100.0% |
| Operating Income | -$377K+99.6% | N/A | $3.9M+41559.1% | -$17.9M-130151.5% | -$92.6M-209058.5% | N/A | -$10K+100.0% | -$14K+100.0% |
| EBITDA | -$252K+99.7% | N/A | $4.1M+45158.5% | -$17.7M-132900.6% | -$92.4M-206584.6% | N/A | -$9K+100.0% | -$13K+100.0% |
| Interest Expense | $4.6M+33.8% | N/A | $5.8M+179221.0% | $4.9M+113279.6% | $3.4M+79540.9% | N/A | $3K-99.9% | $4K-99.9% |
| Income Tax | $0 | N/A | $0-100.0% | $43K | $0-100.0% | N/A | $713-99.0% | $0 |
| Net Income | -$6.8M+89.6% | N/A | $19.9M+230601.2% | -$17.9M-183818.1% | -$65.1M-146965.3% | N/A | -$9K+100.0% | $10K+100.0% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
BENFW Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $250.9M-25.0% | $238.8M-32.7% | $337.9M-15.5% | $316.2M-14.3% | $334.5M-7.4% | $354.9M-3.7% | $400.0M-20.1% | $368.8M-74.7% |
| Cash & Equivalents | $5.6M-26.7% | $2.5M+88.9% | $7.9M+189512.0% | $4.9M+109270.8% | $7.6M+172939.3% | $1.3M-83.0% | $4K-100.0% | $4K-99.8% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $9.9M0.0% | $9.9M0.0% | $9.9M+99900.0% | $9.9M+99900.0% | $9.9M+96981.9% | $9.9M-27.1% | $10K-100.0% | $10K-100.0% |
| Total Liabilities | $435.0M-4.4% | $428.1M+9.8% | $466.4M+20.9% | $459.1M+20.2% | $454.9M-10.7% | $389.8M-30.5% | $385.8M-22.3% | $382.0M+39.6% |
| Total Equity | -$184.1M-52.9% | -$189.3M-442.0% | -$128.6M-901691.9% | -$142.8M-1082578.9% | -$120.4M-81090.2% | -$34.9M+81.8% | $14K-99.6% | -$13K-100.0% |
| Retained Earnings | -$2.1B-1.4% | -$2.1B-4.4% | -$2.1B-102369.6% | -$2.1B-103808.9% | -$2.1B-102961.4% | -$2.0B+2.5% | -$2.0M+99.9% | -$2.0M+99.9% |
Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities, Non-Current Liabilities, Long-Term Debt.
BENFW Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$4.1M+62.1% | -$4.0M+52.9% | -$9.4M-93639.4% | -$14.5M-168594.8% | -$10.8M-101675.1% | -$8.4M | -$10K+100.0% | -$9K+99.9% |
| Depreciation & Amortization | $125K-48.3% | $220K-50.3% | $141K+31443.6% | $143K+36472.9% | $242K+58354.1% | $443K | $447-100.0% | $391-100.0% |
| Stock-Based Compensation | $185K-59.9% | N/A | $367K-54.4% | $462K-86.3% | $461K-53.6% | N/A | $804K-60.3% | $3.4M-60.4% |
| Capital Expenditures | $0-100.0% | $0-100.0% | $0-100.0% | $0-100.0% | $96K+14357.8% | $124K | $42-100.0% | $269-99.9% |
| Free Cash Flow | -$4.1M+62.4% | -$4.0M+53.6% | -$9.4M-93247.3% | -$14.5M-163485.2% | -$10.9M-96549.3% | -$8.6M | -$10K+100.0% | -$9K+99.9% |
| Investing Cash Flow | $6.9M-73.9% | $2.0M-81.7% | $16.4M+263765.7% | $16.4M+342942.7% | $26.5M+413776.7% | $10.7M | $6K-99.9% | $5K-100.0% |
| Financing Cash Flow | $233K+102.5% | -$3.3M+35.6% | -$4.1M-128559.1% | -$4.6M-116133.6% | -$9.4M-943894.1% | -$5.1M | $3K-100.0% | $4K+100.2% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
BENFW Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -3.1% | N/A | 21.1% | -178640.0% | -926480.0% | N/A | -215.3% | -160.2% |
| Net Margin | -55.8% | N/A | 106.7% | -179070.0% | -650760.0% | N/A | -195.5% | 113.9% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | -60.6%+23218.4pp | N/A |
| Return on Assets | -2.7%+16.8pp | N/A | 5.9%+5.9pp | -5.7%-5.7pp | -19.4%-19.5pp | N/A | 0.0%+184.8pp | 0.0%+26.2pp |
| Debt-to-Equity | N/A | N/A | N/A | N/A | N/A | N/A | 27.05-97.9x | N/A |
| Asset Turnover | 0.050.0x | N/A | 0.060.0x | 0.000.0x | 0.000.0x | N/A | 0.010.0x | 0.02+0.1x |
| FCF Margin | -33.7% | N/A | -50.2% | -145280.0% | -109320.0% | N/A | -227.2% | -103.7% |
Not reported in any period shown, so not listed: Gross Margin, Current Ratio.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Note: Shareholder equity is negative (-$189.3M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Where Beneficient Warrant Ranks
Frequently Asked Questions
What is Beneficient Warrant's annual revenue?
Beneficient Warrant (BENFW) reported $40K in total revenue for fiscal year 2026. This represents a -9.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Beneficient Warrant's revenue growing?
Beneficient Warrant (BENFW) revenue declined by 9.1% year-over-year, from $44K to $40K in fiscal year 2026.
Is Beneficient Warrant profitable?
No, Beneficient Warrant (BENFW) reported a net income of -$87.4M in fiscal year 2026.
What is Beneficient Warrant's EBITDA?
Beneficient Warrant (BENFW) had EBITDA of -$165.8M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
What is Beneficient Warrant's free cash flow?
Beneficient Warrant (BENFW) recorded an outflow of $38.8M in free cash flow during fiscal year 2026. That is unchanged from the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Beneficient Warrant's operating cash flow?
Beneficient Warrant (BENFW) recorded an outflow of $38.7M in operating cash flow during fiscal year 2026, representing cash used by core business activities.
What are Beneficient Warrant's total assets?
Beneficient Warrant (BENFW) had $238.8M in total assets as of fiscal year 2026, including both current and long-term assets.
What are Beneficient Warrant's capital expenditures?
Beneficient Warrant (BENFW) invested $96K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
What is Beneficient Warrant's return on assets (ROA)?
Beneficient Warrant (BENFW) had a return on assets of -36.6% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
How does Beneficient Warrant's liquidity compare with its operating cash outflow?
At the end of fiscal year 2026, Beneficient Warrant (BENFW) held $2.5M in cash, cash equivalents and investments, and reported an operating cash outflow of $38.7M over that year. Dividing the one by the other, the reported balance equals about 1 month of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is Beneficient Warrant's debt-to-equity ratio negative or not reported?
Beneficient Warrant (BENFW) has negative shareholder equity of -$189.3M as of fiscal year 2026, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Beneficient Warrant's Piotroski F-Score?
Beneficient Warrant (BENFW) has a Piotroski F-Score of 2 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Beneficient Warrant's earnings high quality?
Beneficient Warrant (BENFW) reported a net loss of $87.4M while operations used $38.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Beneficient Warrant cover its interest payments?
Beneficient Warrant (BENFW) reported an operating loss of $166.5M against $18.8M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.